Bristol-Myers Squibb to Announce Results for the Second Quarter of 2008 on July 24
More News related to BMY
- Top 10 News Items 10/6-10/10: Dow Plunges 18% This Week; UK to Inject Capital Into Banking System; Iceland Melts-down, Seizes Largest Bank
- Introducing Pediatric Care Online(TM)
- Bristol-Myers Squibb and Capital Health System to Host Health Fair and Visits by Hollywood Star Joey Pantoliano and 'Help Is Here Express' Bus to Raise Awareness about Chronic Diseases and P
- Notable Analyst Rating Changes 10/08: BMY, NUE, SYMC Upgraded; TM, X, UPS, F, GM Downgraded
- David Moenning's Daily State of the Markets: 10/08
More News related to Press Releases
- Canaccord Adams Downgrades Freeport-McMoRan (FCX) to Sell, Slashes Price Target
- Jefferies Downgrades Advanced Medical Optics (EYE) to Underperform
- Susquehanna Downgrades Isle of Capri Casinos (ISLE) to Neutral
- Susquehanna Downgrades Boyd Gaming Corporation (BYD) to Neutral
- Susquehanna Downgrades MGM MIRAGE (MGM) to Neutral
NEW YORK--(BUSINESS WIRE)--
Bristol-Myers Squibb Company (NYSE: BMY) will announce results for the second quarter of 2008 on Thursday, July 24. During a 10:30 a.m. (ET) conference call on July 24, company executives will review financial information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at www.bms.com/ir or by dialing 913-312-0976, confirmation code: 2526349. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. (ET) on July 24 through midnight (ET) on August 7. The replay will be available through www.bms.com/ir or by dialing 402-280-9013, confirmation code: 2526349.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life.
Source: Bristol-Myers Squibb Company
Related Categories
Press ReleasesStocks Mentioned
-0.42Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
